The contribution of histopathology to the diagnosis of tuberculosis. Lessons from archival biopsy samples.


Journal

Revista medica de Chile
ISSN: 0717-6163
Titre abrégé: Rev Med Chil
Pays: Chile
ID NLM: 0404312

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 05 11 2022
accepted: 25 09 2023
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 2 8 2024
Statut: ppublish

Résumé

Histopathological analysis of tissue samples is an ancillary complementary diagnostic tool in tuberculosis (TB) with variable sensitivity and specificity according to different clinical settings. We evaluated the spectrum of histological findings, their diagnostic sensitivity, diagnostic utility, and requests over time in a sample of archival biopsies. Analysis of biopsies of confirmed TB cases between years 2011-2019 at a reference hospital in Chile. The series included patients with a histological study for TB confirmed by culture (88.9%) or PCR (11.1%). In total, 34 samples were available for analysis, most of them of extrapulmonary origin (82.4%). Biopsies were taken before the start of treatment in 26 cases (76.5%) or after the start-end of treatment for different reasons in 8 cases (23.5%). Restricting the analysis to the group with pretreatment biopsies, the prevalence/diagnostic sensitivity of granulomas was 93.3%, 69.2% for caseous necrosis, 26.9% for granulomas with caseous necrosis without acid-fast bacilli (AFB), and 46.2% for AFB in any histological context. A histological score was constructed to evaluate the homogeneity of lesions, observing that 76.9% had at least four of the six components of the score. The request for biopsies was maintained over time despite the increase in the use of molecular techniques. The presence of AFB contributed to the diagnosis before microbiological results in 23.1% of the cases. Histological study continues to contribute to the diagnosis of TB, especially in extrapulmonary forms.

Sections du résumé

BACKGROUND BACKGROUND
Histopathological analysis of tissue samples is an ancillary complementary diagnostic tool in tuberculosis (TB) with variable sensitivity and specificity according to different clinical settings. We evaluated the spectrum of histological findings, their diagnostic sensitivity, diagnostic utility, and requests over time in a sample of archival biopsies.
METHODS METHODS
Analysis of biopsies of confirmed TB cases between years 2011-2019 at a reference hospital in Chile.
RESULTS RESULTS
The series included patients with a histological study for TB confirmed by culture (88.9%) or PCR (11.1%). In total, 34 samples were available for analysis, most of them of extrapulmonary origin (82.4%). Biopsies were taken before the start of treatment in 26 cases (76.5%) or after the start-end of treatment for different reasons in 8 cases (23.5%). Restricting the analysis to the group with pretreatment biopsies, the prevalence/diagnostic sensitivity of granulomas was 93.3%, 69.2% for caseous necrosis, 26.9% for granulomas with caseous necrosis without acid-fast bacilli (AFB), and 46.2% for AFB in any histological context. A histological score was constructed to evaluate the homogeneity of lesions, observing that 76.9% had at least four of the six components of the score. The request for biopsies was maintained over time despite the increase in the use of molecular techniques. The presence of AFB contributed to the diagnosis before microbiological results in 23.1% of the cases.
CONCLUSIONS CONCLUSIONS
Histological study continues to contribute to the diagnosis of TB, especially in extrapulmonary forms.

Identifiants

pubmed: 39093154
pii: S0034-98872023000901177
doi: 10.4067/s0034-98872023000901177
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177-1184

Auteurs

Cristiân Carrasco (C)

Servicio de Anatomía Patológica, Hospital Base de Valdivia, Chile.

Alberto Fica (A)

Instituto de Medicina, Facultad de Medicina, Universidad Austral de Chile, Chile.

Carola Osorio (C)

Laboratorio de Tuberculosis, Hospital Base de Valdivia, Chile.

Carlos Munoz (C)

Servicio de Medicina, Hospital Base de Valdivia, Chile.

Felipe Olivares (F)

Servicio de Medicina, Hospital Base de Valdivia, Chile.

Maritza Navarrete (M)

Laboratorio de Biología Molecular, Hospital Base de Valdivia, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH